Alpine Auto Brokers Appoints Fang Gao to Board

What Happened Alpine Auto Brokers, Inc. (OTC: ALTB) filed a Form 8‑K on September 18, 2026 stating that the Board appointed Ms. Fang Gao as a director, effective immediately. The filing notes Ms. Gao’s management and industry experience in biotechnology and health care, including senior roles at Tangshan Future Biotechnology Co., Ltd. (2016–2021) and her service since December 2021 as Chairwoman and General Manager of Hangzhou Gongshengyuan Biotechnology Co., Ltd.

Key Details

• Appointment effective date: September 18, 2026 (reported on Form 8‑K, Accession No. 0001829126-26-010209).
• Prior roles (2016–2021) at Tangshan Future Biotechnology: Assistant to the Chairman, Vice President of Operations, and Executive President.
• Current role since Dec 2021: Chairwoman and General Manager, Hangzhou Gongshengyuan Biotechnology Co., Ltd.
• Education: undergraduate degree in Traditional Chinese Medicine (Heilongjiang University of Chinese Medicine) and a graduate degree in Industrial Economics (Wuhan University of Technology). The filing does not disclose any compensation arrangements tied to this appointment.

Why It Matters Board appointments matter because directors shape oversight, strategy and corporate governance. Ms. Gao’s operational and industry background could inform Alpine Auto Brokers’ strategic discussions, particularly if the company pursues initiatives touching healthcare, operations or related partnerships. Investors should watch for future filings that disclose any committee assignments, compensation, or related-party matters tied to this appointment.